Global and United States Benign Prostatic Hyperplasia (BPH) Drugs Market Research by Company, Type & Application 2013-2025
SUMMARY
Market Segment as follows:
By Type
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Market Segment as follows:
By Type
- Alpha-blocker
- Phosphodiesterase Type-5 Inhibitors
- 5-alpha-Reductase Inhibitors
- Hospitals
- Clinics
- Others
- Astellas Pharma
- Eli Lilly
- GlaxoSmithKline
- Sanofi
- ADC Therapeutics
- Bayer HealthCare
- Bristol-Myers Squibb
- Valeant Pharmaceuticals
- Endo Pharmaceuticals
- Foresee Pharmaceuticals
- Madrigal Pharmaceuticals
- Merck
- Novartis
- Spectrum Pharmaceuticals
- Takeda Pharmaceuticals
- Teva
- Advaxis
- ANI Pharmaceuticals
- BHR Pharma
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Alpha-blocker
1.1.2.2 Phosphodiesterase Type-5 Inhibitors
1.1.2.3 5-alpha-Reductase Inhibitors
1.1.3 Market by Application
1.1.3.1 Hospitals
1.1.3.2 Clinics
1.1.3.3 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Astellas Pharma
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Eli Lilly
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 GlaxoSmithKline
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Sanofi
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 ADC Therapeutics
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Bayer HealthCare
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Bristol-Myers Squibb
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Valeant Pharmaceuticals
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Endo Pharmaceuticals
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Foresee Pharmaceuticals
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Madrigal Pharmaceuticals
6.12 Merck
6.13 Novartis
6.14 Spectrum Pharmaceuticals
6.15 Takeda Pharmaceuticals
6.16 Teva
6.17 Advaxis
6.18 ANI Pharmaceuticals
6.19 BHR Pharma
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Alpha-blocker
1.1.2.2 Phosphodiesterase Type-5 Inhibitors
1.1.2.3 5-alpha-Reductase Inhibitors
1.1.3 Market by Application
1.1.3.1 Hospitals
1.1.3.2 Clinics
1.1.3.3 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Astellas Pharma
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Eli Lilly
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 GlaxoSmithKline
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Sanofi
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 ADC Therapeutics
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Bayer HealthCare
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Bristol-Myers Squibb
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Valeant Pharmaceuticals
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Endo Pharmaceuticals
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Foresee Pharmaceuticals
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Madrigal Pharmaceuticals
6.12 Merck
6.13 Novartis
6.14 Spectrum Pharmaceuticals
6.15 Takeda Pharmaceuticals
6.16 Teva
6.17 Advaxis
6.18 ANI Pharmaceuticals
6.19 BHR Pharma
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
LIST OF TABLES
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Table Sales Revenue, Volume, Price, Cost and Margin of ADC Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer HealthCare
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Table Sales Revenue, Volume, Price, Cost and Margin of Valeant Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Endo Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Foresee Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Madrigal Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Spectrum Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Takeda Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Teva
Table Sales Revenue, Volume, Price, Cost and Margin of Advaxis
Table Sales Revenue, Volume, Price, Cost and Margin of ANI Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of BHR Pharma
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Table Sales Revenue, Volume, Price, Cost and Margin of ADC Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer HealthCare
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Table Sales Revenue, Volume, Price, Cost and Margin of Valeant Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Endo Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Foresee Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Madrigal Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Spectrum Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Takeda Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Teva
Table Sales Revenue, Volume, Price, Cost and Margin of Advaxis
Table Sales Revenue, Volume, Price, Cost and Margin of ANI Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of BHR Pharma
LIST OF FIGURES
Figure Alpha-blocker Market Size and CAGR 2013-2017 (Million USD)
Figure Alpha-blocker Market Size and CAGR 2013-2017 (Volume)
Figure Alpha-blocker Market Forecast and CAGR 2018-2025 (Million USD)
Figure Alpha-blocker Market Forecast and CAGR 2018-2025 (Volume)
Figure Phosphodiesterase Type-5 Inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure Phosphodiesterase Type-5 Inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure Phosphodiesterase Type-5 Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure Phosphodiesterase Type-5 Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure 5-alpha-Reductase Inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure 5-alpha-Reductase Inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure 5-alpha-Reductase Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure 5-alpha-Reductase Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure Hospitals Market Size and CAGR 2013-2017 (Million USD)
Figure Hospitals Market Size and CAGR 2013-2017 (Volume)
Figure Hospitals Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hospitals Market Forecast and CAGR 2018-2025 (Volume)
Figure Clinics Market Size and CAGR 2013-2017 (Million USD)
Figure Clinics Market Size and CAGR 2013-2017 (Volume)
Figure Clinics Market Forecast and CAGR 2018-2025 (Million USD)
Figure Clinics Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Volume)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Benign Prostatic Hyperplasia (BPH) Drugs SWOT List
Figure Life & Medical Porter's Five Forces
Figure Alpha-blocker Market Size and CAGR 2013-2017 (Million USD)
Figure Alpha-blocker Market Size and CAGR 2013-2017 (Volume)
Figure Alpha-blocker Market Forecast and CAGR 2018-2025 (Million USD)
Figure Alpha-blocker Market Forecast and CAGR 2018-2025 (Volume)
Figure Phosphodiesterase Type-5 Inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure Phosphodiesterase Type-5 Inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure Phosphodiesterase Type-5 Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure Phosphodiesterase Type-5 Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure 5-alpha-Reductase Inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure 5-alpha-Reductase Inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure 5-alpha-Reductase Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure 5-alpha-Reductase Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure Hospitals Market Size and CAGR 2013-2017 (Million USD)
Figure Hospitals Market Size and CAGR 2013-2017 (Volume)
Figure Hospitals Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hospitals Market Forecast and CAGR 2018-2025 (Volume)
Figure Clinics Market Size and CAGR 2013-2017 (Million USD)
Figure Clinics Market Size and CAGR 2013-2017 (Volume)
Figure Clinics Market Forecast and CAGR 2018-2025 (Million USD)
Figure Clinics Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Volume)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Benign Prostatic Hyperplasia (BPH) Drugs SWOT List
Figure Life & Medical Porter's Five Forces
